QuidelOrtho发布ADLM 2026播客集锦，未披露订单、获批或财务增量

SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026 Association for Diagnostics and Laboratory Medicine (ADLM) Annual Conference.
Hosted by Stephanie Kleewein, the special episode showcases three presentations addressing some of healthcare's most pressing challenges: delivering faster molecular diagnostic results, improving antibiotic stewardship and accelerating cardiovascular assessment.
Featured guests include Dr. Heather Danks, Chief Technology Officer at LEX Diagnostics; Dr. Mike Broyles, Director of Medical Affairs for Biomarkers at Thermo Fisher Scientific; and Dr. Lindy Carlstrom, Medical Affairs Manager at QuidelOrtho. Together, they discuss how innovation is helping clinicians gain faster, more actionable insights when time matters most.
Key Insights:
- Ultra-fast RT-PCR technology can deliver respiratory test results in as little as six minutes and complete results in less than 10 minutes
- Simplified workflows are helping expand molecular testing into near-patient and CLIA-waived settings
- Procalcitonin (PCT) provides clinicians with a reliable biomarker to support antibiotic stewardship and reduce unnecessary antibiotic use
- Real-world PCT implementation has been associated with reductions in antibiotic exposure, readmissions and adverse events
- High-sensitivity troponin testing enables faster assessment of patients presenting with suspected cardiac events
- Advances in diagnostic precision are helping emergency departments improve patient flow and support timely clinical decisions
Across molecular diagnostics, infectious disease management and cardiovascular care, the conversation highlights a common goal: providing clinicians with rapid, actionable information that supports confident decision-making and better patient outcomes.
Listen to the latest episode of the QuidelOrtho Science Bytes podcast on major streaming platforms or at https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
[email protected]
Media Contact:
Stephanie Kleewein
Senior Corporate Communication and PR Manager
[email protected]
SOURCE QuidelOrtho Corporation